IOLCP Stock View

IOL Chemicals and Pharmaceuticals Ltd

IOLCP Stock View

(NSE)

Trade

₹ 475.7

-3.30 | -0.69

Market Cap ₹( Cr.)
27,926.21

Proj. P/E (x)
12.62

Proj. P/BV (x)
1.63

Proj. ROE (%)
13.80

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)
25,767.50

STRONG BUY

Last Updated On.
17-Sep-2023

 

Copy Link

IOL Chemicals and Pharmaceuticals Limited is an India-based active pharma ingredients (API) based pharmaceutical company. The Company's APIs portfolio covers various therapeutic categories, such as pain management, anti-diabetic, anti-hypertensive, and anti-convulsant, amongst others. The Company operates through two business divisions: Active Pharma Ingredients (API), and Specialty Chemicals. Its API vertical is engaged in research, developing, and providing various essential products that are used by pharma companies. Its API product portfolio includes Ibuprofen, Ibuprofen Lysinate, Ibuprofen Sodium, Dex-Ibuprofen, Metformin HCL, Clopidogrel Bisulphate (Form II), Pantoprazole Sodium, Fenofibrate, Gabapentin, Lamotrigine, Ursodeoxycholic Acid, Losartan Potassium and Levetiracetam. Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride and Mono Chloro Acetic Acid.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data